Kura Drug Patent Portfolio
Kura owns 1 orange book drug protected by 8 US patents Given below is the list of Kura's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12410184 | Crystalline Forms Of A Menin Inhibitor | 16 Jul, 2044 | Active |
| US12521396 | 16 Jul, 2044 | Active | |
| US11944627 | Methods For Treating Hematological Malignancies And Ewing'S Sarcoma | 06 Sep, 2038 | Active |
| US10781218 | Substituted Inhibitors Of Menin-Mll And Methods Of Use | 15 Mar, 2037 | Active |
| US11673898 | Substituted Inhibitors Of Menin-Mll And Methods Of Use | 15 Mar, 2037 | Active |
| US10869868 | Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression In Npm1 Mutant Leukemia | 26 Jan, 2037 | Active |
| US10077271 | Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins | 16 Mar, 2036 | Active |
| US10174041 | Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins | 16 Mar, 2036 | Active |
Latest Legal Activities on Kura's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Kura.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Terminal Disclaimer Filed | 11 Sep, 2025 | US12521396 |
| PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED | 11 Sep, 2025 | US12521396 |
| Interview Summary - Examiner Initiated - Telephonic | 10 Sep, 2025 | US12521396 |
| Disposal for a RCE / CPA / R129 | 10 Sep, 2025 | US12521396 |
| Email Notification | 10 Sep, 2025 | US12521396 |
| Date Forwarded to Examiner | 10 Sep, 2025 | US12521396 |
| Information Disclosure Statement considered | 10 Sep, 2025 | US12521396 |
| Change in Power of Attorney (May Include Associate POA) | 10 Sep, 2025 | US12521396 |
| Recordation of Patent eGrant | 09 Sep, 2025 | US12410184 |
| Email Notification | 09 Sep, 2025 | US12410184 |
| Patent Issue Date Used in PTA Calculation | 09 Sep, 2025 | US12410184 |
| Mail Patent eGrant Notification | 09 Sep, 2025 | US12410184 |
| Patent eGrant Notification | 09 Sep, 2025 | US12410184 |
| Oath or Declaration Filed (Including Supplemental) | 08 Sep, 2025 | US12521396 |
| Miscellaneous Incoming Letter | 08 Sep, 2025 | US12521396 |
Kura's Family Patents
Kura Drug List
Given below is the complete list of Kura's drugs and the patents protecting them.
1. Komzifti
Komzifti is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12410184 | Crystalline Forms Of A Menin Inhibitor |
16 Jul, 2044
(18 years from now)
| Active |
| US12521396 |
16 Jul, 2044
(18 years from now)
| Active | |
| US11944627 | Methods For Treating Hematological Malignancies And Ewing'S Sarcoma |
06 Sep, 2038
(12 years from now)
| Active |
| US10781218 | Substituted Inhibitors Of Menin-Mll And Methods Of Use |
15 Mar, 2037
(11 years from now)
| Active |
| US11673898 | Substituted Inhibitors Of Menin-Mll And Methods Of Use |
15 Mar, 2037
(11 years from now)
| Active |
| US10869868 | Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression In Npm1 Mutant Leukemia |
26 Jan, 2037
(10 years from now)
| Active |
| US10077271 | Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins |
16 Mar, 2036
(10 years from now)
| Active |
| US10174041 | Methods And Compositions For Inhibiting The Interaction Of Menin With Mll Proteins |
16 Mar, 2036
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Komzifti's drug page